These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9583632)

  • 1. State legislators' perceptions of lobbyists and lobbying on tobacco control issues.
    Cohen JE; Goldstein AO; Flynn BS; Munger MC; Gottlieb NH; Solomon LJ; Dana GS
    Tob Control; 1997; 6(4):332-6. PubMed ID: 9583632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. State legislators' attitudes and voting intentions toward tobacco control legislation.
    Goldstein AO; Cohen JE; Flynn BS; Gottlieb NH; Solomon LJ; Dana GS; Bauman KE; Munger MC
    Am J Public Health; 1997 Jul; 87(7):1197-200. PubMed ID: 9240112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are tobacco industry campaign contributions influencing state legislative behavior?
    Monardi F; Glantz SA
    Am J Public Health; 1998 Jun; 88(6):918-23. PubMed ID: 9618620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tobacco industry campaign contributions are affecting tobacco control policymaking in California.
    Glantz SA; Begay ME
    JAMA; 1994 Oct; 272(15):1176-82. PubMed ID: 7933347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. State tobacco lobbyists and organizations in the United States: crossed lines.
    Goldstein AO; Bearman NS
    Am J Public Health; 1996 Aug; 86(8):1137-42. PubMed ID: 8712274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kentucky legislators' views on tobacco policy.
    Hahn EJ; Toumey CP; Rayens MK; McCoy CA
    Am J Prev Med; 1999 Feb; 16(2):81-8. PubMed ID: 10343882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of Canadian legislators' support for tobacco control policies.
    Cohen JE; de Guia NA; Ashley MJ; Ferrence R; Northrup DA; Studlar DT
    Soc Sci Med; 2002 Sep; 55(6):1069-76. PubMed ID: 12220090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Where there's smoke there's money: tobacco industry campaign contributions and U.S. Congressional voting.
    Luke DA; Krauss M
    Am J Prev Med; 2004 Dec; 27(5):363-72. PubMed ID: 15556735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tobacco Industry Influences in the Oklahoma Legislature.
    Matheny JD; Wagener TL; Anderson MP
    J Okla State Med Assoc; 2015 Nov; 108(11):441-9. PubMed ID: 26817060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short report. How provincial and territorial legislators view tobacco and tobacco control: findings from a Canadian study.
    de Guia NA; Cohen JE; Ashley MJ; Ferrence R; Northrup DA; Pollard JS
    Chronic Dis Can; 1998; 19(2):57-61. PubMed ID: 9664026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tobacco industry, state politics, and tobacco education in California.
    Begay ME; Traynor M; Glantz SA
    Am J Public Health; 1993 Sep; 83(9):1214-21. PubMed ID: 8362994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of failed tobacco control legislation.
    Moore S; Wolfe SM; Lindes D; Douglas CE
    JAMA; 1994 Oct; 272(15):1171-5. PubMed ID: 7933346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. State legislators' intentions to vote and subsequent votes on tobacco control legislation.
    Flynn BS; Dana GS; Goldstein AO; Bauman KE; Cohen JE; Gottlieb NH; Solomon LJ; Munger MC
    Health Psychol; 1997 Jul; 16(4):401-4. PubMed ID: 9237093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. State legislators' beliefs about legislation that restricts youth access to tobacco products.
    Gottlieb NH; Goldstein AO; Flynn BS; Cohen EJ; Bauman KE; Solomon LJ; Munger MC; Dana GS; McMorris LE
    Health Educ Behav; 2003 Apr; 30(2):209-24. PubMed ID: 12693524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Money, politics, and medicine: the American Medical PAC's strategy of giving in U.S. house races.
    Wilkerson JD; Carrell D
    J Health Polit Policy Law; 1999 Apr; 24(2):335-55. PubMed ID: 10321360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lobbying Expenditures and Campaign Contributions by the Pharmaceutical and Health Product Industry in the United States, 1999-2018.
    Wouters OJ
    JAMA Intern Med; 2020 May; 180(5):688-697. PubMed ID: 32125357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure to defend a successful state tobacco control program: policy lessons from Florida.
    Givel MS; Glantz SA
    Am J Public Health; 2000 May; 90(5):762-7. PubMed ID: 10800426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How do physicians lobby their members of Congress?
    Landers SH; Sehgal AR
    Arch Intern Med; 2000 Nov; 160(21):3248-51. PubMed ID: 11088085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Power of one: nurses and tobacco control.
    Gallagher J; Holm L
    Semin Oncol Nurs; 1996 Nov; 12(4):270-5. PubMed ID: 8936642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tobacco lobby political influence on US state legislatures in the 1990s.
    Givel MS; Glantz SA
    Tob Control; 2001 Jun; 10(2):124-34. PubMed ID: 11387532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.